Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy
Francesca Fianchi, Antonio Liguori, Antonio Gasbarrini, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6485-6485
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 75
The Role of Insulin Resistance in Fueling NAFLD Pathogenesis: From Molecular Mechanisms to Clinical Implications
Rossella Palma, Annamaria Pronio, Mario Romeo, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 13, pp. 3649-3649
Open Access | Times Cited: 41
Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
Manfredi Rizzo, Alessandro Colletti, Peter E. Penson, et al.
Pharmacological Research (2023) Vol. 189, pp. 106679-106679
Open Access | Times Cited: 38
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
Gao-Xin Xu, Wei Song, Chao Yu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 27
Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Prevotella copri Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Enterotype
Heng Yuan, Xuangao Wu, Xichun Wang, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2183-2183
Open Access | Times Cited: 11
Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis
Yong‐Yu Yang, Li Xie, Ning‐Ping Zhang, et al.
Acta Pharmacologica Sinica (2022) Vol. 43, Iss. 5, pp. 1180-1190
Open Access | Times Cited: 36
The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis—A Systematic Review, Meta-Analysis and Meta-Regression
Anna Gudan, Dominika Jamioł-Milc, Viktoria Hawryłkowicz, et al.
Nutrients (2022) Vol. 14, Iss. 24, pp. 5261-5261
Open Access | Times Cited: 34
Autophagy Dysregulation in Metabolic Associated Fatty Liver Disease: A New Therapeutic Target
Chun‐Liang Chen, Yu‐Cheng Lin
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10055-10055
Open Access | Times Cited: 28
Are Ingested or Inhaled Microplastics Involved in Nonalcoholic Fatty Liver Disease?
Teresa Auguet, Laia Bertran, Andrea Barrientos‐Riosalido, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 20, pp. 13495-13495
Open Access | Times Cited: 28
Small Intestinal Bacterial Overgrowth and Non-Alcoholic Fatty Liver Disease: What Do We Know in 2023?
Anna Gudan, Katarzyna Kozłowska‐Petriczko, Ewa Wunsch, et al.
Nutrients (2023) Vol. 15, Iss. 6, pp. 1323-1323
Open Access | Times Cited: 21
Role of gut microbiota and immune cells in metabolic-associated fatty liver disease: clinical impact
Anna Alisi, Geoffrey W. McCaughan, Henning Grønbæk
Hepatology International (2024) Vol. 18, Iss. S2, pp. 861-872
Closed Access | Times Cited: 7
Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention
Lucrezia Irene Maria Campagnoli, Nicoletta Marchesi, Mariapia Vairetti, et al.
Cells (2022) Vol. 11, Iss. 18, pp. 2827-2827
Open Access | Times Cited: 24
The synbiotic combination of probiotics and inulin improves NAFLD though modulating gut microbiota
Can Zhang, Tianqi Fang, Linlin Shi, et al.
The Journal of Nutritional Biochemistry (2023) Vol. 125, pp. 109546-109546
Closed Access | Times Cited: 14
Bacillus coagulans TCI711 Supplementation Improved Nonalcoholic Fatty Liver by Modulating Gut Microbiota: A Randomized, Placebo-Controlled, Clinical Trial
Rong‐Hong Hsieh, Yu‐Ju Chien, Wen-Yi Lan, et al.
Current Developments in Nutrition (2024) Vol. 8, Iss. 3, pp. 102083-102083
Open Access | Times Cited: 4
Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease
Daniela Ciobârcă, Adriana Florinela Cătoi, Laura Gavrilaș, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 279-279
Open Access
In Vitro, In Vivo, and In Silico Investigation of Synbiotic‐Mediated Activation of PPAR‐α Curtails Nonalcoholic Steatohepatitis (NASH) in Wistar Rats by Inhibiting PNPLA3/SREBP1‐c Lead Inflammatory Injury of Hepatic Cells
Dixa Sharma, Dhara Patel, Palash Mandal
Mediators of Inflammation (2025) Vol. 2025, Iss. 1
Open Access
Gut Microbiota and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Emerging Pathogenic Mechanisms and Therapeutic Implications
Farah Abdelhameed, A.I. Mustafa, Chris Kite, et al.
Livers (2025) Vol. 5, Iss. 1, pp. 11-11
Open Access
Mechanistic insights into the pleiotropic effects of butyrate as a potential therapeutic agent on NAFLD management: A systematic review
Parichehr Amiri, Sara Arefhosseini, Farnush Bakhshimoghaddam, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 21
Microbiota Dysbiosis and Gut Barrier Dysfunction Associated with Non-Alcoholic Fatty Liver Disease Are Modulated by a Specific Metabolic Cofactors’ Combination
Sergio Quesada‐Vázquez, Caitlin Bone, Shikha Saha, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13675-13675
Open Access | Times Cited: 19
Extraction and characterization of polysaccharide from fermented mycelia of Coriolus versicolor and its efficacy for treating nonalcoholic fatty liver disease
Huiling Tang, Zhengqi Zha, Yanfang Tan, et al.
International Journal of Biological Macromolecules (2023) Vol. 248, pp. 125951-125951
Closed Access | Times Cited: 12
Research Progress on the Therapeutic Effect of Polysaccharides on Non-Alcoholic Fatty Liver Disease through the Regulation of the Gut–Liver Axis
Xiang Chen, Menghan Liu, Jun Tang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11710-11710
Open Access | Times Cited: 16
Sex-Specific Associations between Gut Microbiome and Non-Alcoholic Fatty Liver Disease among Urban Chinese Adults
Jiajun Shi, Yaohua Yang, Wanghong Xu, et al.
Microorganisms (2021) Vol. 9, Iss. 10, pp. 2118-2118
Open Access | Times Cited: 18
Effects of long‐term simulated microgravity on liver metabolism in rhesus macaques
Beibei Zong, Yujia Wang, Jingyi Wang, et al.
The FASEB Journal (2022) Vol. 36, Iss. 10
Closed Access | Times Cited: 13
Endogenous n-3 PUFAs Improve Non-Alcoholic Fatty Liver Disease through FFAR4-Mediated Gut–Liver Crosstalk
Xuan Jiang, Qin Yang, Hongyan Qu, et al.
Nutrients (2023) Vol. 15, Iss. 3, pp. 586-586
Open Access | Times Cited: 7
The effect of synbiotics in patients with NAFLD: a systematic review and meta-analysis
Jiacheng Cai, Jia Dong, Dahua Chen, et al.
Therapeutic Advances in Gastroenterology (2023) Vol. 16
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top